MOACM
EGRX

Mutual of America Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Mutual of America Capital Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,115
Closed -$56K – 1607
2022
Q3 		$56K Buy
2,115
+238
+13% +$8.73K ﹤0.01% 1593
2022
Q2 		$83K Buy
1,877
+240
+15% +$11K ﹤0.01% 1541
2022
Q1 		$81K Buy
1,637
+85
+5% +$4.08K ﹤0.01% 1561
2021
Q4 		$79K Buy
1,552
+15
+1% +$777 ﹤0.01% 1578
2021
Q3 		$86K Sell
1,537
-121
-7% -$5.95K ﹤0.01% 1564
2021
Q2 		$71K Buy
1,658
+110
+7% +$4.54K ﹤0.01% 1618
2021
Q1 		$65K Buy
1,548
+95
+7% +$4.41K ﹤0.01% 1614
2020
Q4 		$68K Sell
1,453
-50
-3% -$2.34K ﹤0.01% 1566
2020
Q3 		$64K Buy
1,503
+1,011
+205% +$44.2K ﹤0.01% 1504
2020
Q2 		$24K Buy
492
+49
+11% +$2.44K ﹤0.01% 1519
2020
Q1 		$20K Buy
443
+82
+23% +$4.12K ﹤0.01% 1497
2019
Q4 		$22K Sell
361
-12
-3% -$716 ﹤0.01% 1549
2019
Q3 		$21K Buy
373
+2
+0.5% +$112 ﹤0.01% 1560
2019
Q2 		$21K Buy
371
+75
+25% +$3.91K ﹤0.01% 1556
2019
Q1 		$15K Buy
296
+21
+8% +$934 ﹤0.01% 1585
2018
Q4 		$11K Buy
275
+65
+31% +$3.35K ﹤0.01% 1596
2018
Q3 		$15K Buy
210
+179
+577% +$13.6K ﹤0.01% 1551
2018
Q2 		$2K Buy
+31
New +$1.95K ﹤0.01% 1641

Other funds holding EGRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SGCIA
Smith Graham & Co Investment Advisors Houston, Texas $868M AUM 24.69% 1-Year Est. Return

Mutual of America Capital Management's EGRX Position: Q4 2022 in Review

Mutual of America Capital Management sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q4 2022, closing a stake of 2,115 shares — an estimated $56K sold.

Mutual of America Capital Management first reported a position in EGRX in Q2 2018 and held it in 18 quarters. The position peaked at $86K in Q3 2021. 152 funds tracked by Wall St. Rank hold EGRX as of Q4 2022.

  • Mutual of America Capital Management reported no remaining Eagle Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Mutual of America Capital Management sold 2,115 Eagle Pharmaceuticals, Inc. shares in Q4 2022, an estimated $56K.
  • Mutual of America Capital Management first reported a position in Eagle Pharmaceuticals, Inc. in Q2 2018 and held it in 18 quarters.
  • Mutual of America Capital Management's Eagle Pharmaceuticals, Inc. position peaked at $86K in Q3 2021.
  • 152 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q4 2022.

Based on Mutual of America Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.